Businessman hands connecting puzzle pieces representing the merging of two companies or joint venture, partnership, Mergers and acquisition concept

Diversey has acquired the global intellectual property rights related to Accelerated Hydrogen Peroxide (AHP), a technology from Virox Technologies, Inc., according to a press release.

AHP is a blend of commonly used ingredients that acts as a germicide and cleaner.

Each year, healthcare-associated infections (HAIs) and food-borne illnesses impact millions of people globally. Over the past decade, Diversey and Virox have partnered to develop a number of AHP-based solutions to address these concerns, including several different brands.

“With a mission to protect and care for people every day, infection prevention is a major focus for Diversey. Adding this intellectual property to our portfolio will enhance our ability to accelerate innovation and grow our position in infection prevention globally,” says Mark Burgess, chief executive officer of Diversey, “It will inform our future investment decisions as we continue to apply science to protect people every day. This major acquisition reaffirms Diversey's global commitment to achieve profitable growth through innovation and acquisition.”

Diversey will continue to license this technology to key partners where the solution can be used to deliver value across other markets.